lanatosides has been researched along with Coronary-Disease* in 29 studies
3 trial(s) available for lanatosides and Coronary-Disease
Article | Year |
---|---|
[Effect of digoxin, isolanide and strophanthin on central hemodynamic indices in acute cardiac insufficiency].
Topics: Acute Disease; Clinical Trials as Topic; Coronary Disease; Digoxin; Drug Evaluation; Hemodynamics; Humans; Lanatosides; Mitral Valve Stenosis; Postoperative Period; Rheumatic Heart Disease; Strophanthins | 1979 |
[Clinical trial of the Bulgarian digitalis preparation, Digilanide C used intravenously].
The Bulgarian digitalis preparation Digilanid C for venous application has a satisc factory effect on the majority of the patients (67 per cent) with light and moderate chronic cardia insufficiency and espically in case of tachycardia in auricular fibrillation. The comparison of the results between the group of 46 patients, treated with Digilanid C and the control group of 20 patients treated with Isolanid (Richter) do not reveal essential differences in the major part of the results obtained. Topics: Adult; Aged; Bulgaria; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Heart Rate; Hemodynamics; Humans; Hypertension; Injections, Intravenous; Lanatosides; Middle Aged; Rheumatic Heart Disease; Tachycardia | 1975 |
Comparative study of the cardiac and peripheral vascular effects of strophantin K and lanatoside C in coronary heart disease.
The effects of intravenous strophanthin K (0.125 and 0.25 MG) and lanatoside C (0.4, 0.8 and 1.6 mg) on systolic time intervals (STI) and impedance plethysmographic (IP)P values were studied in ten patients with compensated coronary heart disease. The heart rate decreased significantly during a two-hour study in the lying position after both glycosides and placebo; the systemic blood pressure remained unchanged. Electromechanical systole (QS2), left ventricular ejection time (LVET) and preejection period (PEP), corrected for heart rate (QS2I, LVETI, PEPI), showed no change after placebo. The glycosides caused no change in LVETI. QS2I was significantly shortened only after lanatoside C 1.6 mg. PEPI and ICT were significantly shortened by both doses of strophanthin K and lanatoside C; the effects were dose-related. Taking into consideration the effects of cardiac glycosides on STI, use of the index ICT/QS1, the quotient of isovolumic contraction time and electro-mechanical delay, is proposed, because it showed quite sensitively the increase in myocardial contractility after digitalis. The effect of strophanthin K could be detected 10 minutes, and that of lanatoside C 30-40 minutes, after injection. The amplitude of the IP curve and the relative pulse volume showed positive and negative changes without any trend after administration of placebo or glycoside. The data suggests that the usual therapeutic doses of these cardiac glycosides do not cause significant changes in the peripheral circulation in patients with compensated coronary heart disease, but their action on STI is quite marked, showing a positive inotropic effect. Topics: Adult; Aged; Coronary Disease; Dose-Response Relationship, Drug; Female; Heart Rate; Heart Sounds; Humans; Lanatosides; Male; Middle Aged; Myocardial Contraction; Plethysmography, Impedance; Strophanthins; Time Factors | 1975 |
26 other study(ies) available for lanatosides and Coronary-Disease
Article | Year |
---|---|
Electrophysiological study on hypertrophied and ischemic myocardial of rats.
Topics: Action Potentials; Animals; Calcium; Cardiomegaly; Coronary Disease; Electrophysiology; Female; Lanatosides; Male; Rats; Rats, Inbred Strains; Verapamil | 1987 |
Effect of sheng mai san on left ventricular performance in coronary heart disease.
Topics: Adult; Aged; Coronary Disease; Drugs, Chinese Herbal; Female; Heart; Heart Function Tests; Humans; Lanatosides; Male; Middle Aged | 1982 |
[Immunological treatment of digitalis poisoning with heterologous antibodies].
Our own experience with the production of digoxin-specific antibody preparations from the sheep and the results of the experimental and clinical use are briefly reviewed. Advantages, risks and unsolved problems of therapy with glycoside-specific antibodies are discussed. Topics: Animals; Antibodies, Heterophile; Coronary Disease; Digitalis Glycosides; Digoxin; Heart Failure; Humans; Lanatosides; Rabbits; Sheep | 1981 |
[Treatment of cardiac insufficiency with lanatigen C].
Topics: Administration, Oral; Adult; Aged; Coronary Disease; Female; Heart Defects, Congenital; Heart Diseases; Humans; Hypertension; Lanatosides; Male; Middle Aged; Pulmonary Heart Disease; Rheumatic Heart Disease; Time Factors | 1979 |
[Acute renal insufficiency in gastroenteritis caused by digitalis intoxication].
Topics: Acute Kidney Injury; Aged; Coronary Disease; Electrocardiography; Female; Gastroenteritis; Humans; Lanatosides; Tachycardia | 1974 |
[Ischemic reaction in patients with coronary vascular diseases during general hypoxia. (Comparison between strophanthin-g and desacetyllanatoside C].
Topics: Adult; Aged; Blood Pressure; Coronary Circulation; Coronary Disease; Female; Heart Rate; Humans; Hypoxia; Ischemia; Lanatosides; Male; Middle Aged; Oxygen; Oxygen Consumption; Partial Pressure; Strophanthins | 1973 |
[Value of polycardiographic tests and radiocardiography for the recognition of hidden heart failure in hypertensive patients].
Topics: Adolescent; Adult; Coronary Disease; Female; Heart Ventricles; Humans; Hypertension; Iodine Radioisotopes; Lanatosides; Male; Middle Aged; Nitroglycerin; Propranolol; Pulmonary Circulation | 1972 |
[Clinical study on the effects of creatinol-O-phosphate in patients with heart diseases under digitalis treatment].
Topics: Aged; Alcohols; Arrhythmias, Cardiac; Coronary Disease; Creatine; Drug Synergism; Drug Tolerance; Female; Hallucinations; Heart Diseases; Heart Failure; Humans; Lanatosides; Male; Middle Aged; Nausea; Nystagmus, Pathologic; Organophosphorus Compounds; Vertigo | 1972 |
[Clinical study of a new digitalic drug in 50 patients: deacetyl lanatoside C].
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Drug Tolerance; Female; Heart Failure; Humans; Lanatosides; Male; Middle Aged | 1972 |
[Clinical use of a coronary dilator and a digitalis glycoside combination].
Topics: Aged; Coronary Disease; Drug Combinations; Electrocardiography; Female; Heart Diseases; Humans; Lanatosides; Male; Middle Aged; Vasodilator Agents | 1972 |
[Clinical study of a new cardiotonic drug, desacetyl-lanatoside C].
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Female; Heart Diseases; Heart Failure; Heart Rate; Humans; Lanatosides; Male; Middle Aged | 1972 |
[Aponal in the therapy of organic coronary blood flow disorders].
Topics: Coronary Disease; Dibenzoxepins; Female; Heart Failure; Humans; Lanatosides; Male; Myocardial Infarction; Vasodilator Agents | 1970 |
[Dynamics of the total left ventricular systole under the influence of cardiac glycosides with particular reference to proscillaridin A].
Topics: Adult; Bufanolides; Cardiac Glycosides; Coronary Disease; Digitalis Glycosides; Electrocardiography; Female; Heart Ventricles; Humans; Lanatosides; Male; Middle Aged; Ouabain | 1969 |
[Our experiences with the beta-adrenolytic preparation Isoptin Knoll A.G].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Coronary Disease; Electrocardiography; Female; Humans; Lanatosides; Male; Myocardial Infarction; Nitriles; Vasodilator Agents; Verapamil | 1969 |
[On the management of coronary insufficiency using Lanacard].
Topics: Aged; Coronary Disease; Digoxin; Female; Humans; Lanatosides; Male; Middle Aged | 1968 |
[Inotropic effect of digitalis. II. Ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Digitalis Glycosides; Electrocardiography; Heart Rate; Humans; Lanatosides; Male; Methods; Middle Aged; Phonocardiography | 1968 |
The role of catecholamines in circulatory regulation on the chronic congestive heart failure. Clinical study of the urinary catecholamine excretion in the patients with chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Blood Pressure; Cardiomyopathies; Catecholamines; Coronary Disease; Digitalis Glycosides; Diuretics; Epinephrine; Female; Glomerular Filtration Rate; Guanethidine; Heart Defects, Congenital; Heart Failure; Heart Valve Diseases; Humans; Hydrochlorothiazide; Hypertension; Lanatosides; Male; Middle Aged; Norepinephrine; Potassium; Regional Blood Flow; Sodium; Spironolactone; Trichlormethiazide | 1968 |
[On the advantages of the use of desacetyl-lanatoside C in cardiokinetic therapy].
Topics: Adult; Aged; Coronary Disease; Female; Heart Failure; Humans; Lanatosides; Male; Middle Aged; Pulmonary Heart Disease | 1967 |
[Acetyldigoxin, a new cardiac glycoside].
Topics: Aged; Atrial Fibrillation; Blood Flow Velocity; Body Weight; Coronary Disease; Electrocardiography; Female; Heart Diseases; Heart Failure; Humans; Hypertension; Hyperthyroidism; Intestinal Absorption; Lanatosides; Male; Middle Aged; Pulmonary Heart Disease; Pulse | 1966 |
HEMODYNAMIC STUDIES AND CLINICAL EXPERIENCE WITH NETHALIDE, A BETA-ADRENERGIC BLOCKING AGENT.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Atrial Fibrillation; Biomedical Research; Coronary Disease; Drug Therapy; Exercise Test; Goiter; Graves Disease; Hemodynamics; Humans; Hypertension; Lanatosides; Sympatholytics; Toxicology | 1965 |
SOME HEMODYNAMIC AND CLINICO-PATHOLOGICAL CONSIDERATION OF CONGESTIVE HEART FAILURE WITH SPECIAL REFERENCE TO THERAPEUTIC EFFECT.
Topics: Aminophylline; Angiotensins; Atrial Fibrillation; Autopsy; Blood Flow Velocity; Blood Pressure; Blood Pressure Determination; Blood Volume; Blood Volume Determination; Cardiac Catheterization; Coronary Disease; Drug Therapy; Endocarditis; Endocarditis, Subacute Bacterial; Heart Defects, Congenital; Heart Failure; Heart Function Tests; Humans; Hypertension; Lanatosides; Mitral Valve Stenosis; Norepinephrine; Pathology; Radioisotopes; Rheumatic Heart Disease; Syphilis; Syphilis, Cardiovascular | 1964 |
[CONTRIBUTION TO THE CLINICAL STUDY OF THE THERAPEUTIC EFFECTS OF DESACETYL-LANATOSIDE C].
Topics: Aortic Valve Stenosis; Arrhythmias, Cardiac; Coronary Disease; Deslanoside; Humans; Hypertension; Lanatosides; Mitral Valve Insufficiency; Mitral Valve Stenosis | 1964 |
COMPLICATIONS AND LIMITATIONS OF DIRECT-CURRENT COUNTERSHOCK.
Topics: Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Coronary Disease; Electric Countershock; Heart Block; Hypertension; Hyperthyroidism; Lanatosides; Quinidine; Rheumatic Heart Disease; Tachycardia; Thoracic Surgery; Toxicology | 1964 |
[ON THE CLINICAL USE OF DESACETYL-LANATOSIDE C].
Topics: Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Coronary Disease; Deslanoside; Heart Defects, Congenital; Heart Failure; Humans; Lanatosides; Myocarditis; Pulmonary Heart Disease; Tachycardia | 1963 |
[RAPID DIGITALIZATION AND MAINTENANCE WITH DESACETYL-LANATOSIDE C; CLINICAL OBSERVATIONS].
Topics: Adolescent; Angina Pectoris; Arrhythmias, Cardiac; Atrial Fibrillation; Child; Coronary Disease; Deslanoside; Geriatrics; Heart Block; Heart Failure; Humans; Hypertension; Lanatosides; Myocardial Infarction; Pharmacology; Pulmonary Edema; Pulmonary Fibrosis; Pulmonary Heart Disease; Tachycardia; Thrombophlebitis; Toxicology; Water-Electrolyte Balance | 1963 |
[Pharmacological and clinical considerations on the association ATP-cardiac glycosides (lanatoside C, strophanthin) in the treatment of arteriosclerotic heart disease].
Topics: Adenosine Triphosphate; Cardiac Glycosides; Coronary Artery Disease; Coronary Disease; Digitalis; Digitalis Glycosides; Lanatosides; Strophanthins | 1959 |